PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS) research hub

A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

This study looks at how safe and well a medicine called Miransertib is for children and adults with certain growth conditions (PROS or Proteus Syndrome). It's for people already in other Miransertib studies or about to start, exploring long-term effects.